- Antifungal Effects of New Synthetic Materials, KAF-200522 and KAF-200522-HCl, on in vitro and in vivo Models
-
Jung JY, Kong KH, Koo KH, Song SW, Kim KH, Han ZZ, Lee YJ, Han JS
- KMID: 2114703
- Lab Anim Res.
- 2010 Dec;26(4):353-359.
- doi: 10.5625/lar.2010.26.4.353
KAF-200522 and its chloride form, KAF-200522-HCl, were invented in Chemon inc. as new triazole antifungal agents with excellent activities in vivo and in vitro against wide range of fungi. As... -
- CITED
-
- Close
- SHARE
-
- Close
- Reference Data of the Main Physiological Parameters in Control Sprague-Dawley Rats from Pre-clinical Toxicity Studies
-
Han ZZ, Xu HD, Kim KH, Ahn TH, Bae JS, Lee JY, Gil KH, Lee JY, Woo SJ, Yoo HJ, Lee HK, Kim KH, Park CK, Zhang HS, Song SW
- KMID: 2312061
- Lab Anim Res.
- 2010 Jun;26(2):153-164.
- doi: 10.5625/lar.2010.26.2.153
The purpose of this paper is to provide reference data related to the body weight, food & water consumptions, urinalysis, hematology and serum biochemistry parameters and absolute & relative organ... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacokinetic and Toxicokinetic Studies of Potential Antifungal Compounds, KAF-200522 and KAF-200522 . HCl, in Animal Models
-
Kong KH, Jung JY, Koo KH, Song SW, Kim KH, Han ZZ, Lee SH, Shin HC
- KMID: 2114709
- Lab Anim Res.
- 2010 Dec;26(4):399-405.
- doi: 10.5625/lar.2010.26.4.399
Recent researches on clinically used triazole antifungal reagents are focused on their pharmacokinetic disadvantage which increases the probability of inducing adverse effects in patients. For this point, in the present... -
- CITED
-
- Close
- SHARE
-
- Close
